BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US SEC Filings Daily Market Digest β€” February 03, 2026

Daily USA Market Intelligence

88 high priority215 medium priority303 total filings analysed

Executive Summary

On February 4, 2026, 303 SEC filings dominated by ~150 earnings-related 8-Ks (Item 2.02) from major names like Alphabet, Eli Lilly, Aflac, Uber, Boston Scientific, Cognizant, GE HealthCare, signaling the kickoff of Q4 earnings season across tech, healthcare, industrials, and financials; no aggregate quantitative PoP trends available as metrics NOT_DISCLOSED in summaries, but neutral sentiment prevails (95%+ filings). M&A activity notable in 30+ filings with Item 1.01/2.01 (e.g., Orion Group acquisition completion, MicroVision asset disposition), mixed with risks like terminations (Launch One) and dilutions (Sangamo). Leadership churn in 40+ Item 5.02 filings indicates potential transitions amid earnings. Bearish outliers include delistings (Inspirato, Dayforce) and impairments (Workday), while high materiality (8+/10) in 100+ cases flags immediate review of exhibits for catalysts. Portfolio implication: Quiet day quantitatively but event-rich for catalysts; focus on exhibit reviews for beats/misses, strategic M&A synergies.

Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from February 02, 2026.

Investment Signals(12)

  • β–²

    Earnings 8-K (Item 2.02), materiality 8/10, neutral sentiment; review exhibits for YoY trucking volume trends post-Q4

  • β–²

    Earnings disclosure (Item 2.02), materiality 8/10; sector leader, monitor for ad revenue QoQ beats vs peers

  • β–²

    Q4 results filing, materiality 7/10; pharma giant, potential GLP-1 guidance reaffirmation in exhibits

  • A10 Networks↓(BULLISH POTENTIAL)
    β–²

    Multi-item earnings (2.02+7.01+8.01), materiality 7/10; cybersecurity, flag for forward guidance on threat volumes

  • Acquisition completion (Item 2.01) with pro forma exhibits, materiality 8/10, mixed sentiment; strategic scale opportunity

  • β–²

    Asset acquisition/disposition complete (Item 2.01), materiality 8/10; potential tech asset bolt-on synergies

  • Merger announcement (Item 8.01), materiality 7/10; SPAC de-SPAC catalyst pending terms review

  • β–²

    Acquisition completion (Item 2.01+1.01), materiality 8/10; strategic expansion potential

  • CECO Environmental↓(BULLISH POTENTIAL)
    β–²

    Material agreement + financial obligation (1.01+2.03), materiality 8/10; growth financing signal

  • β–²

    Acquisition complete (2.01) + material agreement, materiality 8/10; aerospace turnaround catalyst

  • Sangamo Therapeutics↓(BULLISH POTENTIAL)
    β–²

    Material agreement (1.01) despite dilution, materiality 7/10 mixed; biotech partnership upside

  • β–²

    Material definitive agreement (1.01), materiality 8/10; medtech growth via partnership/M&A

Risk Flags(10)

  • Material agreement termination (Item 1.02), bearish sentiment, high risk/materiality 9/10

  • β–Ό

    Delisting notice (3.01), change in control (5.01), termination (1.02), high risk/materiality 10/10

  • β–Ό

    Delisting (3.01), control change (5.01), acquisition/termination mix, high risk/materiality 10/10

  • Triller Group↓[MEDIUM RISK]
    β–Ό

    Auditor change (Item 4.01), medium risk/materiality 8/10; potential accounting disagreements

  • β–Ό

    Material impairments (2.06) + exit costs (2.05), bearish/high risk/materiality 9/10

  • Pacific Oak Strategic REIT[HIGH RISK]
    β–Ό

    Financial obligation acceleration (2.04), bearish/high risk/materiality 8/10

  • PAVmed Inc.↓[MEDIUM RISK]
    β–Ό

    Agreement termination (1.02) + dilution (3.02), mixed/medium risk 8/10

  • Cuentas Inc.↓[MEDIUM RISK]
    β–Ό

    Shareholder rights mods (3.03) + material agreement, mixed/medium risk 8/10 dilution potential

  • β–Ό

    Security holder rights material mods (3.03), medium risk 7/10

  • Multiple officer changes (5.02) across filings, pattern signals transition uncertainty

Opportunities(10)

Sector Themes(6)

  • Earnings Season Surge
    β—†

    ~150 Item 2.02 filings (e.g., Alphabet, Lilly, Uber, Cognizant, GE HealthCare), neutral sentiment/high materiality avg 7.5/10; review exhibits cluster-wide for QoY revenue/margin beats vs consensus, catalyst for sector rotations

  • M&A Momentum in Small Caps/SPACs
    β—†

    30+ Item 1.01/2.01 (Orion, MicroVision, Valuence, Inspirato), mixed sentiment; completions outpace terminations 3:1, spot undervalued targets via pro formas

  • Leadership Transition Wave
    β—†

    40+ Item 5.02 officer changes (Uber, FuelCell, Freshpet, NRG), neutral/low materiality; monitor for conviction via follow-on insider buys, pattern in tech/industrials

  • Dilution/Financing Risks in Microcaps
    β—†

    15+ Item 3.02 unregistered equity (Sangamo, PAVmed, Haymaker SPAC), medium risk; paired with agreements (1.01), signals cap raises but EPS pressure

  • Bearish Distress Signals Rare but Acute
    β—†

    5 high-risk delistings/impairments/terminations (Inspirato, Dayforce, Workday, Launch One), contrast neutral backdrop; short/avoid clusters

  • Neutral Reg FD Clusters
    β—†

    20+ Item 7.01 (A10, Blue Bird, Cencora), voluntary guidance flags; aggregate for forward catalysts absent PoP data

Watch List(8)

Filing Analyses(303)
OLD DOMINION FREIGHT LINE, INC.8-Kneutralmateriality 8/10

04-02-2026

OLD DOMINION FREIGHT LINE, INC. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036791) disclosing Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

Unknown8-Kneutralmateriality 8/10

04-02-2026

The company filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037195), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, or other quantitative metrics are disclosed in the provided filing details. No positive or negative performance indicators, period-over-period comparisons, or guidance are mentioned.

  • Β·File size: 6 MB (minor detail)
ECO SCIENCE SOLUTIONS, INC.8-Kneutralmateriality 6/10

04-02-2026

ECO SCIENCE SOLUTIONS, INC. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are provided in the filing summary. This is a voluntary earnings-related disclosure with no mentioned positive or negative performance indicators.

EASTGROUP PROPERTIES INC8-Kneutralmateriality 7/10

04-02-2026

EastGroup Properties Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0000049600-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet effects, guidance changes, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard multi-item voluntary disclosure typical for financial results announcements.

A10 Networks, Inc.8-Kneutralmateriality 7/10

04-02-2026

A10 Networks, Inc. filed a Form 8-K on February 04, 2026 (AccNo: 0001580808-26-000005), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed. No positive or negative performance details, period-over-period comparisons, or transaction values are provided.

Blue Bird Corp8-Kneutralmateriality 8/10

04-02-2026

Blue Bird Corp filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. This multi-item filing provides no period-over-period comparisons or directional performance indicators.

AFLAC INC8-Kneutralmateriality 7/10

04-02-2026

Aflac Incorporated filed a Form 8-K on February 4, 2026 (AccNo: 0001628280-26-005458), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are provided in the excerpt. No period-over-period comparisons, guidance, or scheduled events are mentioned.

EPLUS INC8-Kneutralmateriality 8/10

04-02-2026

ePlus inc filed a Form 8-K on February 4, 2026 (AccNo: 0001022408-26-000017), reporting Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This multi-item filing pertains to financial results but no specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided details. No positive or negative performance indicators, period-over-period changes, or balance sheet impacts are mentioned.

Alphabet Inc.8-Kneutralmateriality 8/10

04-02-2026

Alphabet Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, guidance, or other financial metrics are disclosed in the provided filing details. No positive or negative performance indicators, period-over-period changes, or transaction values were mentioned.

  • Β·Accession Number: 0001652044-26-000012
  • Β·File Size: 752 KB
ELI LILLY & Co8-Kneutralmateriality 7/10

04-02-2026

Eli Lilly & Co filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified performance metrics.

Orion Group Holdings Inc8-Kmixedmateriality 8/10

04-02-2026

Orion Group Holdings Inc filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), which represents a significant corporate event. However, the filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and unregistered sales of equity securities (Item 3.02), introducing potential debt and dilution risks. Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01) are included, but no specific deal terms or financial metrics are detailed.

Warner Bros. Discovery, Inc.DEFA14Amateriality 4/10

04-02-2026

TREASURE GLOBAL INC8-K/Amateriality 4/10

04-02-2026

AXON ENTERPRISE, INC.8-K/Amateriality 4/10

04-02-2026

MILESTONE SCIENTIFIC INC.8-K/Amateriality 4/10

04-02-2026

ConnectM Technology Solutions, Inc.8-Kneutralmateriality 5/10

04-02-2026

ConnectM Technology Solutions, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. The disclosure appears informational without quantified positive or negative impacts.

STANLEY BLACK & DECKER, INC.8-Kneutralmateriality 5/10

04-02-2026

Stanley Black & Decker, Inc. filed an 8-K on February 4, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

ARES CAPITAL CORP8-Kneutralmateriality 8/10

04-02-2026

Ares Capital Corp filed a Form 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. This multi-item filing includes attached financial statements but no specific metrics, changes, or comparisons disclosed in the provided details. No positive or negative performance indicators are available.

  • Β·AccNo: 0001287750-26-000004
  • Β·File Size: 521 KB
Yum China Holdings, Inc.8-Kneutralmateriality 8/10

04-02-2026

Yum China Holdings, Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. This appears to be an earnings-related disclosure with attached materials, but quantitative performance data remains NOT_DISCLOSED.

Allied Gaming & Entertainment Inc.8-Kneutralmateriality 6/10

04-02-2026

Allied Gaming & Entertainment Inc. filed a Form 8-K on February 04, 2026, reporting under Item 5.07 the results of matters submitted to a vote of security holders, Item 7.01 a Regulation FD Disclosure, and Item 9.01 listing financial statements and exhibits. No specific vote outcomes, disclosure details, numerical metrics, or financial impacts are disclosed in the provided filing summary.

COOPER COMPANIES, INC.8-Kneutralmateriality 8/10

04-02-2026

Cooper Companies, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. No specific details on the agreement's nature, parties, dollar value, or financial impacts are disclosed. This is a multi-item filing focused on a material event, but lacks quantitative metrics or comparisons.

Sky Harbour Group Corp8-Kneutralmateriality 3/10

04-02-2026

Sky Harbour Group Corp filed an 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction details, financial impacts, or exhibits are disclosed in the provided filing information. This appears to be a multi-item filing with limited transparency on materiality.

Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 4/10

04-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary.

HANOVER INSURANCE GROUP, INC.8-Kneutralmateriality 7/10

04-02-2026

HANOVER INSURANCE GROUP, INC. filed a Form 8-K on February 04, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were mentioned. Sector details are not specified.

  • Β·AccNo: 0001193125-26-036103
  • Β·Filing size: 7 MB
MICROVISION, INC.8-Kneutralmateriality 8/10

04-02-2026

MicroVision, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001493152-26-004952, Size: 204 KB) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides for financial statements and exhibits related to the event. No specific details on transaction parties, value, structure, or impacts are disclosed.

LAM RESEARCH CORP8-K/Aneutralmateriality 3/10

04-02-2026

LAM Research Corp filed an 8-K on February 4, 2026 (AccNo: 0000707549-26-000014), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.

Triller Group Inc.8-Kneutralmateriality 8/10

04-02-2026

Triller Group Inc. filed a Form 8-K on February 04, 2026, specifically under Item 4.01 reporting changes in its certifying accountant. No additional details such as the identity of the prior or new accountant, reasons for the change (e.g., resignation, dismissal, disagreements), financial impacts, or strategic context are disclosed in the filing summary. This is a mandatory single-item disclosure with no quantitative metrics provided.

Launch One Acquisition Corp.8-Kbearishmateriality 9/10

04-02-2026

Launch One Acquisition Corp. filed an 8-K on 2026-02-04 announcing the termination of a material definitive agreement under Item 1.02. Item 9.01 discloses financial statements and exhibits, but no specific details, metrics, or context are provided. No positive developments or offsetting information reported.

CaliberCos Inc.8-Kneutralmateriality 4/10

04-02-2026

CaliberCos Inc. filed a Form 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with Accession Number 0001627282-26-000002 and file size 413 KB. This is a multi-item voluntary disclosure likely including material non-public information and attached exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

  • Β·Accession Number: 0001627282-26-000002
Midland States Bancorp, Inc.8-Kneutralmateriality 3/10

04-02-2026

Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

NEWS CORP8-Kneutralmateriality 4/10

04-02-2026

News Corp filed a Form 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary provided. This is a multi-item informational filing with no quantitative metrics, transactions, or directional impacts explicitly stated.

CITY HOLDING CO8-Kneutralmateriality 2/10

04-02-2026

CITY HOLDING CO filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This is a multi-item informational filing with no quantitative metrics or directional impacts provided.

Keurig Dr Pepper Inc.8-Kneutralmateriality 2/10

04-02-2026

Keurig Dr Pepper Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial impacts, transactions, or metrics are disclosed in the filing summary. This appears to be a multi-item informational filing with attached exhibits.

Bunge Global SA8-Kneutralmateriality 7/10

04-02-2026

Bunge Global SA filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing details. This is an informational disclosure of financial results with no directional performance indicators available.

Unknown8-Kneutralmateriality 8/10

04-02-2026

The filer submitted an 8-K on February 4, 2026 (AccNo: 0001213900-26-011634), disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition event, alongside unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or financial terms are provided in the filing description. This represents a significant corporate development but lacks quantitative data or strategic rationale for assessment.

BOSTON SCIENTIFIC CORP8-Kneutralmateriality 8/10

04-02-2026

Boston Scientific Corp filed a Form 8-K on February 4, 2026 (AccNo: 0000885725-26-000006), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet effects, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified metrics.

COGNIZANT TECHNOLOGY SOLUTIONS CORP8-Kneutralmateriality 8/10

04-02-2026

Cognizant Technology Solutions Corp filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing summary. No positive or negative performance details, period-over-period comparisons, or balance sheet effects are mentioned.

GE HealthCare Technologies Inc.8-Kneutralmateriality 8/10

04-02-2026

GE HealthCare Technologies Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided information. This represents a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

  • Β·AccNo: 0001932393-26-000006
  • Β·Filing size: 1 MB
  • Β·Event Type: Financial Results
  • Β·Sector: not specified
Oaktree Specialty Lending Corp8-Kneutralmateriality 7/10

04-02-2026

Oaktree Specialty Lending Corp filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, with Item 9.01 attaching financial statements and exhibits. No specific revenue, earnings, balance sheet changes, or period-over-period comparisons were disclosed in the provided filing summary. This represents a standard mandatory earnings-related disclosure without quantified metrics.

Eva Live Inc8-Kneutralmateriality 3/10

04-02-2026

Eva Live Inc filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary provided. This is a multi-item filing with no quantitative data or directional impacts mentioned.

Inspirato Inc8-Kmixedmateriality 10/10

04-02-2026

Inspirato Inc filed an 8-K on 2026-02-04 announcing the completion of an acquisition or disposition of assets (Item 2.01) alongside a change in control of the registrant (Item 5.01). However, the filing also discloses termination of a material definitive agreement (Item 1.02), notice of delisting or failure to satisfy a continued listing rule (Item 3.01), and material modifications to rights of security holders (Item 3.03), which may negatively impact liquidity and shareholder value. Additional disclosures include changes in directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD information (Item 7.01).

BIO-TECHNE Corp8-Kneutralmateriality 7/10

04-02-2026

BIO-TECHNE Corp filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided information. This is a multi-item filing typical for earnings releases, but detailed financial data and period-over-period comparisons are NOT_DISCLOSED.

Valuence Merger Corp. I8-Kneutralmateriality 7/10

04-02-2026

Valuence Merger Corp. I filed an 8-K on February 4, 2026 (AccNo: 0001493152-26-004997) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed. Sector is not specified.

Cencora, Inc.8-Kneutralmateriality 9/10

04-02-2026

Cencora, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are provided in the available information.

Avery Dennison Corp8-Kneutralmateriality 7/10

04-02-2026

Avery Dennison Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned. All quantitative financial metrics and performance details are NOT_DISCLOSED.

EQUIFAX INC8-Kneutralmateriality 7/10

04-02-2026

Equifax Inc filed an 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

KENNAMETAL INC8-Kneutralmateriality 5/10

04-02-2026

Kennametal Inc. filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005264), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard earnings-related disclosure with exhibits likely containing press release or financial tables, but key metrics are NOT_DISCLOSED.

Evercore Inc.8-Kneutralmateriality 7/10

04-02-2026

Evercore Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure without detailed performance data.

Haymaker Acquisition Corp. 48-Kneutralmateriality 5/10

04-02-2026

Haymaker Acquisition Corp. 4 filed an 8-K on 2026-02-04 (AccNo: 0001104659-26-010028, Size: 274 KB) disclosing unregistered sales of equity securities under Item 3.02, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, and financial statements and exhibits under Item 9.01. No quantitative metrics, period-over-period comparisons, deal structure details, parties involved, valuation, synergies, or other transaction specifics are explicitly stated. No positive or negative performance metrics are present.

VISHAY INTERTECHNOLOGY INC8-Kneutralmateriality 7/10

04-02-2026

Vishay Intertechnology Inc filed an 8-K on February 4, 2026 (AccNo: 0000103730-26-000008), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.

TIMKEN CO8-Kneutralmateriality 7/10

04-02-2026

Timken Co filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with all key performance data NOT_DISCLOSED.

WABASH NATIONAL Corp8-Kneutralmateriality 5/10

04-02-2026

Wabash National Corp filed an 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.

Uber Technologies, Inc8-Kneutralmateriality 6/10

04-02-2026

Uber Technologies, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or financial metrics are disclosed. The filing size is 696 KB with AccNo 0001543151-26-000011.

Bit Digital, Inc8-Kneutralmateriality 4/10

04-02-2026

Bit Digital, Inc. filed a Form 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosure content, transaction values, financial metrics, or exhibits provided.

Adient plc8-Kneutralmateriality 7/10

04-02-2026

Adient plc filed a Form 8-K on February 4, 2026 (AccNo: 0001670541-26-000022), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned. This is a standard earnings-related disclosure with no directional performance data provided.

SILICON LABORATORIES INC.8-Kneutralmateriality 7/10

04-02-2026

Silicon Laboratories Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing details. This is a standard earnings-related disclosure without detailed performance data.

PRICE T ROWE GROUP INC8-Kneutralmateriality 7/10

04-02-2026

Price T Rowe Group Inc filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005273), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results with attached exhibits, but no specific revenue, earnings, margins, or other quantitative metrics are disclosed in the provided filing details. No period-over-period comparisons, guidance, or material changes are mentioned.

LEAR CORP8-Kneutralmateriality 8/10

04-02-2026

Lear Corp filed a Form 8-K on 2026-02-04 (AccNo: 0000842162-26-000005, size 538 KB) reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard financial results disclosure without directional indicators on performance.

CME GROUP INC.8-Kneutralmateriality 8/10

04-02-2026

CME Group Inc. filed an 8-K on February 04, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure with no quantitative metrics available for analysis.

CDW Corp8-Kneutralmateriality 7/10

04-02-2026

CDW Corp filed a Form 8-K on February 04, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard earnings-related 8-K with attached exhibits, but detailed results are NOT_DISCLOSED.

SILICON LABORATORIES INC.8-Kneutralmateriality 8/10

04-02-2026

Silicon Laboratories Inc. filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for the material agreement, likely filed timely within 4 business days. Specific details on the agreement, transaction value, parties, financial impacts, or other metrics are NOT_DISCLOSED.

NEW YORK TIMES CO8-Kneutralmateriality 8/10

04-02-2026

New York Times Co filed an 8-K on February 4, 2026 (AccNo: 0000071691-26-000008, Size: 1 MB), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. This is a standard multi-item filing for financial results disclosure. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information.

  • Β·Event Type: Financial Results
  • Β·Source: us_sec
  • Β·Sector: NOT_DISCLOSED
Reynolds Consumer Products Inc.8-Kneutralmateriality 5/10

04-02-2026

Reynolds Consumer Products Inc. filed an 8-K on 2026-02-04 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information. This is a multi-item earnings-related disclosure with attached exhibits, but quantitative details are NOT_DISCLOSED.

VALVOLINE INC8-Kneutralmateriality 5/10

04-02-2026

Valvoline Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing summary. This is a multi-item filing typical for quarterly earnings releases.

Johnson Controls International plc8-Kneutralmateriality 7/10

04-02-2026

Johnson Controls International plc filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the filing summary provided. Critical financial details are likely in attached exhibits but not extracted here.

YUM BRANDS INC8-Kneutralmateriality 9/10

04-02-2026

YUM Brands Inc filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This represents a standard multi-item earnings-related disclosure.

IDEX CORP /DE/8-Kneutralmateriality 5/10

04-02-2026

IDEX Corp (/DE/) filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

Azenta, Inc.8-Kneutralmateriality 7/10

04-02-2026

Azenta, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified results available.

  • Β·Filing Accession Number: 0001437749-26-002876
  • Β·Filing Size: 889 KB
  • Β·Event Type: Financial Results
  • Β·Sector: NOT_DISCLOSED
Performance Food Group Co8-Kneutralmateriality 4/10

04-02-2026

Performance Food Group Co filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data.

FLEX LTD.8-Kneutralmateriality 8/10

04-02-2026

FLEX LTD. filed a Form 8-K on February 4, 2026 (AccNo: 0000866374-26-000002, Size: 472 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, likely including a press release and attachments. No specific revenue, earnings, guidance, comparisons, or other quantitative financial metrics are explicitly stated in the provided filing information.

FUELCELL ENERGY INC8-Kneutralmateriality 6/10

04-02-2026

FUELCELL ENERGY INC filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details such as key positions affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.

Fortive Corp8-Kneutralmateriality 8/10

04-02-2026

Fortive Corp filed an 8-K on February 4, 2026 (AccNo: 0001659166-26-000003, Size: 785 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No quantitative financial metrics, revenue, earnings, guidance, period-over-period comparisons, positive or negative changes, or other specific data are explicitly stated in the filing description. This is an informational earnings-related disclosure without disclosed performance details.

Verastem, Inc.8-Kneutralmateriality 8/10

04-02-2026

Verastem, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010036), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary filing typical for quarterly financial results announcements. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed.

Medalist Diversified REIT, Inc.8-Kneutralmateriality 8/10

04-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010034), reporting entry into a material definitive agreement under Item 1.01, with exhibits attached under Item 9.01. No specific details on the agreement terms, parties, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

TEXAS INSTRUMENTS INC8-Kneutralmateriality 4/10

04-02-2026

Texas Instruments Inc filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-036727), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the content of the Regulation FD disclosure or the nature of the financial statements/exhibits provided in the filing summary. No quantitative metrics, transactions, or performance data (positive, negative, or flat) were disclosed.

Unknown8-Kneutralmateriality 5/10

04-02-2026

The company filed an 8-K on February 4, 2026 (AccNo: 0001213900-26-011821) under Item 8.01 Other Events disclosing a Merger/Acquisition event. No quantitative metrics, parties involved, deal structure, valuation, strategic rationale, or timelines are mentioned. This is purely informational with all key details NOT_DISCLOSED.

Lamb Weston Holdings, Inc.8-Kneutralmateriality 3/10

04-02-2026

Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-04 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data are disclosed.

Lumen Technologies, Inc.8-K/Amateriality 4/10

04-02-2026

Fox Corp8-Kneutralmateriality 7/10

04-02-2026

Fox Corp filed an 8-K on 2026-02-04 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard mandatory disclosure for financial results with no detailed metrics available.

Freshpet, Inc.8-Kneutralmateriality 4/10

04-02-2026

Freshpet, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

LCI INDUSTRIES8-Kneutralmateriality 5/10

04-02-2026

LCI Industries filed an 8-K on February 4, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information previously shared selectively under Regulation FD, with exhibits attached (file size 700 KB). No financial metrics, transactions, period-over-period changes, or scheduled events are explicitly stated in the filing summary.

AbbVie Inc.8-Kneutralmateriality 7/10

04-02-2026

AbbVie Inc. filed an 8-K on 2026-02-04 under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.

Functional Brands Inc.8-Kneutralmateriality 7/10

04-02-2026

Functional Brands Inc. filed a Form 8-K on February 4, 2026, under Item 3.03 disclosing material modifications to rights of security holders. Item 9.01 lists financial statements and exhibits. No specific details on the modifications, financial impacts, dollar values, or quantitative metrics were provided.

Fusemachines Inc.8-Kneutralmateriality 8/10

04-02-2026

Fusemachines Inc. filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, parties, financial impacts, or metrics are disclosed.

UNITED RENTALS, INC.8-Kneutralmateriality 5/10

04-02-2026

UNITED RENTALS, INC. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

AMERICAN FINANCIAL GROUP INC8-Kneutralmateriality 9/10

04-02-2026

AMERICAN FINANCIAL GROUP INC filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-036749), disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a standard multi-item filing for financial results with no specific revenue, earnings, or other quantitative metrics disclosed in the provided information. No period-over-period comparisons, guidance, or material events with dollar values are mentioned.

DT Cloud Star Acquisition Corp8-Kneutralmateriality 3/10

04-02-2026

DT Cloud Star Acquisition Corp filed an 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No merger/acquisition details, quantitative metrics, parties, valuations, or performance data were explicitly stated in the filing summary. No positive, negative, or flat metrics reported.

Allarity Therapeutics, Inc.8-Kneutralmateriality 3/10

04-02-2026

Allarity Therapeutics, Inc. filed an 8-K on 2026-02-04 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events or contents of the exhibits are disclosed. This is an informational filing without quantified financial metrics, changes, or directional impacts.

PAVmed Inc.8-Kmixedmateriality 8/10

04-02-2026

PAVmed Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of another (Item 1.02), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, share counts, or financial impacts are provided in the filing summary. These events suggest potential restructuring or financing activities, but lack of specifics limits assessment of net positive or negative implications.

Entera Bio Ltd.8-Kneutralmateriality 8/10

04-02-2026

Entera Bio Ltd. filed a Form 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, personnel names, or directional impacts (positive or negative) were specified. This is a multi-item informational filing with no disclosed period-over-period comparisons or flat performance indicators.

AMERICAN AXLE & MANUFACTURING HOLDINGS INC8-Kneutralmateriality 2/10

04-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing, but specific details of the other events, transactions, or exhibits are NOT_DISCLOSED in the provided information. No financial metrics, changes, or impacts are mentioned.

Reservoir Media, Inc.8-Kneutralmateriality 5/10

04-02-2026

Reservoir Media, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard earnings-related disclosure with no directional performance indicators available.

Howard Hughes Holdings Inc.8-Kneutralmateriality 4/10

04-02-2026

Howard Hughes Holdings Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010052), reporting under Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing summary. This multi-item filing is primarily informational with attached exhibits.

GRI Bio, Inc.8-Kneutralmateriality 5/10

04-02-2026

GRI Bio, Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data were disclosed in the provided filing details. The disclosure appears informational without directional performance indicators.

SANGAMO THERAPEUTICS, INC8-Kmixedmateriality 7/10

04-02-2026

Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. The filing represents a multi-item disclosure of a potentially strategic transaction but also potential share dilution from equity sales. No specific transaction values, share counts, financial impacts, or strategic details are disclosed.

Cuentas Inc.8-Kmixedmateriality 8/10

04-02-2026

Cuentas Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and material modifications to rights of security holders under Item 3.03, alongside Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing lacks specific details on transaction terms, financial impacts, or quantitative metrics. Modifications to shareholder rights may introduce dilution risks, while the new agreement could signal strategic opportunities.

enVVeno Medical Corp8-Kneutralmateriality 3/10

04-02-2026

enVVeno Medical Corp filed an 8-K on February 4, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, quantitative data, period-over-period comparisons, or transaction details were mentioned in the provided filing information. This is a multi-item filing likely related to earnings release or operational updates, but lacks detailed content for deeper analysis.

MATTHEWS INTERNATIONAL CORP8-Kneutralmateriality 7/10

04-02-2026

Matthews International Corp filed an 8-K on February 4, 2026 (AccNo: 0000063296-26-000011), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing for financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, comparisons, or directional indicators are provided in the filing summary.

Coherus Oncology, Inc.8-Kneutralmateriality 3/10

04-02-2026

Coherus Oncology, Inc. filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the event, financial impacts, transactions, or quantitative metrics are disclosed in the filing information provided. This appears to be a single-item voluntary disclosure with unknown materiality.

TWIN DISC INC8-Kneutralmateriality 5/10

04-02-2026

Twin Disc Inc filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This appears to be a voluntary informational filing with attached exhibits.

TWIN DISC INC8-Kneutralmateriality 8/10

04-02-2026

TWIN DISC INC filed an 8-K on February 4, 2026 (AccNo: 0001437749-26-002877, Size: 502 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are provided in the filing summary.

International Land Alliance Inc.8-Kneutralmateriality 6/10

04-02-2026

International Land Alliance Inc. filed a Form 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 5.07 submission of matters to a vote of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed. This multi-item filing provides governance and shareholder-related updates without specified positive or negative impacts.

NightFood Holdings, Inc.8-Kneutralmateriality 4/10

04-02-2026

NightFood Holdings, Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or quantitative data were disclosed in the provided filing summary. The nature of the Regulation FD disclosure and contents of any exhibits remain NOT_DISCLOSED.

Brookfield Asset Management Ltd.8-Kneutralmateriality 7/10

04-02-2026

Brookfield Asset Management Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. No specific details on leadership changes, financial metrics, names, positions, reasons, or quantitative data are disclosed in the provided filing information.

CERO THERAPEUTICS HOLDINGS, INC.8-Kneutralmateriality 3/10

04-02-2026

CERO Therapeutics Holdings, Inc. filed Form 8-K on 2026-02-04 reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the events, transactions, financial metrics, or exhibits are disclosed.

CECO ENVIRONMENTAL CORP8-Kneutralmateriality 8/10

04-02-2026

CECO Environmental Corp filed an 8-K on 2026-02-04 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 provides Financial Statements and Exhibits. No quantitative details, terms, positive or negative metrics, or directional impacts are disclosed.

  • Β·AccNo: 0001193125-26-036815
  • Β·File Size: 2 MB
  • Β·Multi-item mandatory 8-K filing
PIPER SANDLER COMPANIES8-Kneutralmateriality 4/10

04-02-2026

Piper Sandler Companies filed an 8-K on 2026-02-04 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

NRG ENERGY, INC.8-Kneutralmateriality 5/10

04-02-2026

NRG Energy, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

Dayforce, Inc.8-Kmixedmateriality 10/10

04-02-2026

Dayforce, Inc. filed an 8-K on 2026-02-04 disclosing completion of an acquisition or disposition of assets (Item 2.01) alongside entry into a new material definitive agreement (Item 1.01), but also termination of another material definitive agreement (Item 1.02), notice of delisting or failure to satisfy listing standards (Item 3.01), and changes in control of the registrant (Item 5.01). Additional disclosures include unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No financial terms, parties, valuations, or quantitative metrics were explicitly stated.

CHOICEONE FINANCIAL SERVICES INC8-Kneutralmateriality 4/10

04-02-2026

CHOICEONE FINANCIAL SERVICES INC filed an 8-K on 2026-02-04 related to an officer change, including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the key position affected, whether it is an appointment or resignation, reason for the change, timing, or any named executives are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or governance implications are mentioned.

  • Β·AccNo: 0000905729-26-000032
  • Β·File Size: 5 MB
  • Β·Event Type: Officer Change
  • Β·Item 5.02 (typical for officer changes) not explicitly listed
MSC INCOME FUND, INC.8-Kneutralmateriality 4/10

04-02-2026

MSC Income Fund, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

  • Β·Filing AccNo: 0001535778-26-000016
  • Β·File size: 294 KB
  • Β·Sector: not specified
VSE CORP8-Kneutralmateriality 7/10

04-02-2026

VSE Corp filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036858) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no quantitative data provided.

Phillips 668-Kneutralmateriality 8/10

04-02-2026

Phillips 66 filed an 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This represents a standard financial results announcement for the company. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

Eagle Bancorp Montana, Inc.8-Kneutralmateriality 3/10

04-02-2026

Eagle Bancorp Montana, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure, which is a voluntary disclosure to ensure broad dissemination of material information. Item 9.01 indicates financial statements and exhibits are attached, but no specific details, metrics, transactions, or events are disclosed in the filing summary. No quantitative financial impacts, guidance changes, or scheduled events are mentioned.

First Northwest Bancorp8-Kneutralmateriality 3/10

04-02-2026

First Northwest Bancorp filed a Form 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. This appears to be a voluntary disclosure with attached materials, but content is NOT_DISCLOSED.

GBank Financial Holdings Inc.8-Kneutralmateriality 5/10

04-02-2026

GBank Financial Holdings Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary public release of material nonpublic information. Item 9.01 lists Financial Statements and Exhibits, but specific details, metrics, or content are NOT_DISCLOSED. No financial impacts, transactions, or performance data are provided in the filing summary.

Unknown8-Kneutralmateriality 3/10

04-02-2026

The company filed a Form 8-K on February 4, 2026, disclosing an unregistered sale of equity securities under Item 3.02. No additional details such as transaction value, share count, parties involved, or financial impact were provided in the filing.

NB Bancorp, Inc.8-Kneutralmateriality 3/10

04-02-2026

NB Bancorp, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010122, size 7 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed. This is a multi-item informational filing with no financial metrics, transactions, or performance data provided.

Unknown8-Kneutralmateriality 5/10

04-02-2026

The company filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified performance data.

MAGELLAN COPPER & GOLD Corp8-Kneutralmateriality 2/10

04-02-2026

MAGELLAN COPPER & GOLD Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001683168-26-000744, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the 'Other Event', transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item, likely voluntary disclosure with no quantified impacts mentioned.

MGM Resorts International8-Kneutralmateriality 8/10

04-02-2026

MGM Resorts International filed an 8-K on February 4, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are mentioned in the provided filing details. No positive or negative performance indicators, guidance, or balance sheet impacts are disclosed.

TYLER TECHNOLOGIES INC8-Kneutralmateriality 3/10

04-02-2026

Tyler Technologies Inc filed an 8-K on February 4, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. The core event details under Item 8.01 are NOT_DISCLOSED, and no specific financial statements, exhibits, or quantitative metrics are described in the filing summary. This appears to be a multi-item informational filing with no disclosed positive or negative performance metrics.

ONCOLYTICS BIOTECH INC8-Kneutralmateriality 3/10

04-02-2026

Oncolytics Biotech Inc. filed a Form 8-K on February 4, 2026, reporting solely under Item 8.01 Other Events. No details on the core event, transaction values, financial metrics, positive or negative impacts, or quantitative data are disclosed in the provided filing information. This is a single-item filing with no specified sector context.

Unknown8-Kneutralmateriality 1/10

04-02-2026

The company filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037206), reporting under Item 8.01 Other Events as a general filing. No specific details on the core event, financial metrics, transactions, or impacts are disclosed in the provided filing information. Sector is not specified.

Nordicus Partners Corp8-Kneutralmateriality 3/10

04-02-2026

Nordicus Partners Corp filed an 8-K on February 4, 2026, reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. Critical quantitative and qualitative data is NOT_DISCLOSED.

  • Β·Item 8.01 used for unspecified other events, which may indicate voluntary disclosure of material information.
  • Β·Item 9.01 indicates exhibits or financial statements attached, but contents NOT_DISCLOSED.
i-80 Gold Corp.8-Kneutralmateriality 5/10

04-02-2026

i-80 Gold Corp. filed an 8-K on 2026-02-04 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any financial metrics are disclosed in the provided filing information.

LANDMARK BANCORP INC8-Kneutralmateriality 5/10

04-02-2026

Landmark Bancorp Inc filed an 8-K on February 4, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the core event, financial metrics, transactions, or performance changes (positive, negative, or flat) are disclosed in the provided filing summary. This filing ensures compliance with Regulation FD for sharing material information.

Unknown8-Kneutralmateriality 3/10

04-02-2026

The company filed an 8-K under Item 8.01 Other Events on February 04, 2026 (AccNo: 0001193125-26-037368, Size: 152 KB). Event type is listed as General Filing with no specific details on the event provided. Sector not specified.

WAFD INC8-Kneutralmateriality 4/10

04-02-2026

WAFD INC filed an 8-K on 2026-02-04 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on leadership changes, such as key positions affected, appointment or resignation reasons, board meeting outcomes, or quantitative metrics, are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

  • Β·AccNo: 0000936528-26-000023
  • Β·File Size: 209 KB
  • Β·Sector: NOT_DISCLOSED
Unknown8-Kneutralmateriality 4/10

04-02-2026

The company filed a Form 8-K on February 4, 2026, disclosing an Item 3.02 event related to unregistered sales of equity securities. No details on transaction value, share count, parties involved, pricing, or strategic purpose were provided. This appears to be a single-item mandatory filing with no accompanying financial metrics or comparisons.

Maison Solutions Inc.8-Kneutralmateriality 8/10

04-02-2026

Maison Solutions Inc. filed an 8-K on February 04, 2026, disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 provides financial statements and exhibits. No specific deal terms, parties, valuations, or financial impacts are disclosed.

Unknown8-Kneutralmateriality 3/10

04-02-2026

The filer submitted a Form 8-K on February 04, 2026 (AccNo: 0001493152-26-005082), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item general filing ensures public dissemination of material nonpublic information previously shared selectively, with exhibits likely attached (file size 234 KB). No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the filing metadata.

Unknown8-Kneutralmateriality 8/10

04-02-2026

The company filed a Form 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits, likely including the agreement details. No quantitative metrics, transaction values, parties, or impacts are specified in the provided filing information.

Unknown8-Kneutralmateriality 8/10

04-02-2026

Company filed an 8-K on 2026-02-04 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, with exhibits under Item 9.01. This is a multi-item mandatory filing likely within the required 4-business-day window given the same-day event and filing dates. No quantitative details, dollar values, strategic context, or financial impacts are disclosed in the provided information.

ARTS WAY MANUFACTURING CO INC8-Kneutralmateriality 5/10

04-02-2026

ARTS WAY MANUFACTURING CO INC filed an 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are mentioned in the provided filing details. This is a multi-item, likely voluntary earnings-related disclosure with no quantified financial impacts disclosed.

Unknown8-Kneutralmateriality 2/10

04-02-2026

The company filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037416, Size: 347 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. Critical information such as the core event description and any exhibits content is missing, limiting analysis depth.

OKMIN RESOURCES, INC.8-Kneutralmateriality 8/10

04-02-2026

OKMIN RESOURCES, INC. filed a Form 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits (AccNo: 0001079973-26-000165, Size: 677 KB). No details on the agreement, transaction value, parties, financial impacts, or metrics are provided in the filing summary. This is a multi-item mandatory disclosure of a material event.

Quipt Home Medical Corp.DEFA14Amateriality 4/10

04-02-2026

KEMPER Corp8-Kneutralmateriality 7/10

04-02-2026

KEMPER Corp filed an 8-K on February 04, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a standard voluntary earnings-related disclosure with no directional financial impacts detailed.

ALT5 Sigma Corp8-Kneutralmateriality 6/10

04-02-2026

ALT5 Sigma Corp filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts were disclosed.

SITIME Corp8-Kneutralmateriality 7/10

04-02-2026

SiTime Corp filed an 8-K on February 04, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard mandatory earnings-related disclosure without detailed performance data.

  • Β·Multi-item 8-K filing (Items 2.02 and 9.01)
  • Β·AccNo: 0001451809-26-000007, Size: 383 KB
  • Β·Event Type: Financial Results
Quipt Home Medical Corp.DEFA14Amateriality 4/10

04-02-2026

Hewlett Packard Enterprise Co8-Kneutralmateriality 2/10

04-02-2026

Hewlett Packard Enterprise Co filed an 8-K on February 4, 2026 (AccNo: 0001645590-26-000006, Size: 180 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, quantitative data, period-over-period comparisons, or other details are explicitly stated in the provided filing information. This is an informational disclosure with no positive or negative metrics disclosed.

AMERICAN SUPERCONDUCTOR CORP /DE/8-Kneutralmateriality 7/10

04-02-2026

AMERICAN SUPERCONDUCTOR CORP /DE/ filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings announcements, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED. No positive or negative performance indicators, period-over-period comparisons, or balance sheet effects are provided in the filing summary.

DIGI INTERNATIONAL INC8-Kneutralmateriality 6/10

04-02-2026

DIGI International Inc filed an 8-K on February 4, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing focused on financial results announcement.

U S PHYSICAL THERAPY INC /NV8-Kneutralmateriality 3/10

04-02-2026

U S PHYSICAL THERAPY INC /NV filed a Form 8-K on February 4, 2026 (AccNo: 0000885978-26-000006, Size: 809 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information. All quantitative and qualitative event specifics are NOT_DISCLOSED.

Boot Barn Holdings, Inc.8-Kneutralmateriality 7/10

04-02-2026

Boot Barn Holdings, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010309), reporting results of operations and financial condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary disclosure typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are available.

KULICKE & SOFFA INDUSTRIES INC8-Kneutralmateriality 7/10

04-02-2026

Kulicke & Soffa Industries Inc filed an 8-K on February 4, 2026 (AccNo: 0000056978-26-000010), disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard financial results announcement with sector not specified.

Global AI, Inc.8-Kneutralmateriality 6/10

04-02-2026

Global AI, Inc. filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

LESAKA TECHNOLOGIES INC8-Kneutralmateriality 6/10

04-02-2026

Lesaka Technologies Inc filed an 8-K on February 4, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.

UNIVERSAL TECHNICAL INSTITUTE INC8-Kneutralmateriality 7/10

04-02-2026

UNIVERSAL TECHNICAL INSTITUTE INC filed an 8-K on February 04, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This is a standard financial results disclosure. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information.

Lifevantage Corp8-Kneutralmateriality 5/10

04-02-2026

Lifevantage Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition (Item 2.02), a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer change, including key position, appointment or resignation status, reasons, timing, or any financial metrics are explicitly stated. No quantitative data, period-over-period comparisons, or scheduled events were disclosed.

ACCURAY INC8-Kneutralmateriality 7/10

04-02-2026

Accuray Inc filed a Form 8-K on February 4, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results from operations but no specific revenue, earnings, or other quantitative metrics are provided in the filing details. No period-over-period comparisons, guidance, or directional performance indicators (positive, negative, or flat) are mentioned.

Quipt Home Medical Corp.DEFM14Amateriality 6/10

04-02-2026

HYCROFT MINING HOLDING CORP8-Kneutralmateriality 3/10

04-02-2026

HYCROFT MINING HOLDING CORP filed a Form 8-K on 2026-02-04 disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, or specific changes are disclosed. This appears to be an informational governance update without evident positive or negative performance indicators.

MCKESSON CORP8-Kneutralmateriality 7/10

04-02-2026

McKesson Corp filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed quantitative data available.

TTM TECHNOLOGIES INC8-Kneutralmateriality 5/10

04-02-2026

TTM Technologies Inc filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

Symbotic Inc.8-Kneutralmateriality 7/10

04-02-2026

Symbotic Inc. filed an 8-K on February 04, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item earnings-related disclosure. Specific financial metrics, performance comparisons, or guidance details are NOT_DISCLOSED.

Unknown8-Kmixedmateriality 8/10

04-02-2026

The company filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 indicates financial statements and exhibits are attached. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed.

ALIGN TECHNOLOGY INC8-Kneutralmateriality 7/10

04-02-2026

Align Technology Inc filed a Form 8-K on February 4, 2026 (AccNo: 0001097149-26-000006), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure without detailed operational or financial data available for analysis.

GOLUB CAPITAL BDC, Inc.8-Kneutralmateriality 7/10

04-02-2026

Golub Capital BDC, Inc. filed an 8-K on February 04, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or guidance details are provided in the filing summary. This is a standard informational disclosure for financial results without quantified metrics.

Aligos Therapeutics, Inc.8-Kneutralmateriality 6/10

04-02-2026

Aligos Therapeutics, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037558, Size: 137 KB) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative metrics are provided. This is a routine SEC-required disclosure for material leadership events with no additional context available.

  • Β·Filing Accession Number: 0001193125-26-037558
  • Β·Filing Size: 137 KB
  • Β·Event Date: 2026-02-04
  • Β·Sector: NOT_DISCLOSED
COHERENT CORP.8-Kneutralmateriality 5/10

04-02-2026

Coherent Corp. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided information. Detailed operational or balance sheet impacts are NOT_DISCLOSED.

ALICO, INC.8-Kneutralmateriality 5/10

04-02-2026

ALICO, INC. filed a Form 8-K on February 4, 2026 (AccNo: 0000003545-26-000010, Size: 464 KB), disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, transaction details, or guidance are explicitly stated in the provided filing summary. This appears to be a standard earnings-related disclosure with attached exhibits.

PC CONNECTION INC8-Kneutralmateriality 7/10

04-02-2026

PC Connection Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific quantitative metrics such as revenue, earnings, guidance, or period-over-period changes are NOT_DISCLOSED. No positive or negative performance indicators, scheduled events, or forward-looking statements are detailed in the provided filing information.

FORMFACTOR INC8-Kneutralmateriality 6/10

04-02-2026

FormFactor Inc. filed an 8-K on February 4, 2026 (AccNo: 0001039399-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a standard earnings release disclosure. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons, positive/negative changes, or flat performance data available.

PagerDuty, Inc.8-Kneutralmateriality 4/10

04-02-2026

PagerDuty, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected position, individual name, appointment or resignation, reasons, or timing are NOT_DISCLOSED.

Workday, Inc.8-Kbearishmateriality 9/10

04-02-2026

Workday, Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition), Item 2.05 (Costs Associated with Exit or Disposal Activities), and Item 2.06 (Material Impairments), indicating a multi-item disclosure. While results of operations may include performance updates, the presence of exit/disposal costs and material impairments points to negative financial pressures such as restructuring and asset write-downs. Specific metrics, dollar values, or period-over-period comparisons are NOT_DISCLOSED.

SUNation Energy, Inc.8-Kneutralmateriality 8/10

04-02-2026

SUNation Energy, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details on the nature of the agreement, financial obligation, transaction value, or any quantitative impacts are NOT_DISCLOSED. No revenue, earnings, balance sheet effects, guidance changes, or other metrics provided.

GOLUB CAPITAL BDC, Inc.8-Kneutralmateriality 6/10

04-02-2026

Golub Capital BDC, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, period-over-period comparisons, revenue, earnings, balance sheet details, or guidance changes are disclosed in the provided filing summary. This is a standard voluntary disclosure for financial results with no quantitative data available for analysis.

Allegiant Travel CO8-Kneutralmateriality 7/10

04-02-2026

Allegiant Travel Company filed a Form 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were explicitly stated in the filing summary. This multi-item filing provides informational disclosure without quantified metrics.

QUALCOMM INC/DE8-Kneutralmateriality 8/10

04-02-2026

QUALCOMM INC/DE filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified performance metrics.

Eureka Acquisition Corp8-Kneutralmateriality 8/10

04-02-2026

Eureka Acquisition Corp filed an 8-K on 2026-02-04 disclosing entry into a Material Definitive Agreement under Item 1.01, likely related to a merger or acquisition event. The filing also reports creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific quantitative metrics, parties involved, deal terms, or performance comparisons are disclosed.

Clearfield, Inc.8-Kneutralmateriality 8/10

04-02-2026

Clearfield, Inc. filed a Form 8-K on 2026-02-04 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure typical for quarterly or annual earnings releases.

EVEREST GROUP, LTD.8-Kneutralmateriality 8/10

04-02-2026

Everest Group, Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned. All detailed financial performance data is NOT_DISCLOSED.

  • Β·AccNo: 0001095073-26-000003
  • Β·File Size: 877 KB
  • Β·Sector: NOT_DISCLOSED
LIPELLA PHARMACEUTICALS INC.8-Kneutralmateriality 5/10

04-02-2026

Lipella Pharmaceuticals Inc. filed an 8-K on February 4, 2026 (AccNo: 0001753926-26-000265), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, named individuals, or any quantitative data such as compensation amounts are disclosed. Sector information is NOT_DISCLOSED.

Howard Hughes Holdings Inc.8-Kneutralmateriality 2/10

04-02-2026

Howard Hughes Holdings Inc. filed an 8-K on 2026-02-04 (AccNo: 0001104659-26-010321, size: 227 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary.

AQUABOUNTY TECHNOLOGIES INC8-K/Aneutralmateriality 8/10

04-02-2026

AquaBounty Technologies Inc. filed an 8-K on 2026-02-04 disclosing Item 5.01 Changes in Control of Registrant and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or compensatory terms are disclosed. No financial metrics, performance data, or quantitative information provided.

OMEGA HEALTHCARE INVESTORS INC8-Kneutralmateriality 5/10

04-02-2026

Omega Healthcare Investors Inc filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.

RMR GROUP INC.8-Kneutralmateriality 6/10

04-02-2026

RMR Group Inc. filed an 8-K on February 4, 2026 (AccNo: 0001644378-26-000006), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative financial data were explicitly stated in the provided filing information. This represents a standard voluntary earnings disclosure without detailed performance metrics available.

Great Elm Group, Inc.8-Kneutralmateriality 5/10

04-02-2026

Great Elm Group, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. This multi-item filing provides informational disclosure on financial results, but no specific revenue, earnings, margins, comparisons, or other metrics are mentioned. No positive or negative performance indicators, guidance, or scheduled events are detailed.

CROWN CASTLE INC.8-Kmixedmateriality 7/10

04-02-2026

Crown Castle Inc. filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. The presence of Item 2.05 signals potential negative costs from restructuring or disposal efforts, while Item 2.02 covers financial results, but no specific revenue, earnings, or cost figures are disclosed. This multi-item filing provides transparency on operations and potential restructuring but lacks quantified metrics for impact assessment.

Lucky Strike Entertainment Corp8-Kneutralmateriality 8/10

04-02-2026

Lucky Strike Entertainment Corp filed an 8-K on February 04, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No quantitative financial metrics, revenue, earnings, guidance, period-over-period comparisons, or balance sheet details were explicitly stated in the provided filing information. Sector is not specified.

ALLSTATE CORP8-Kneutralmateriality 6/10

04-02-2026

Allstate Corp filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing details provided. This appears to be a standard earnings-related disclosure without quantified positive or negative changes.

CENTRAL GARDEN & PET CO8-Kneutralmateriality 8/10

04-02-2026

CENTRAL GARDEN & PET CO filed a Form 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

CORPAY, INC.8-Kneutralmateriality 8/10

04-02-2026

CORPAY, INC. filed a Form 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided information. This is a multi-item filing typical for quarterly earnings releases with no quantitative metrics available.

EnerSys8-Kneutralmateriality 7/10

04-02-2026

EnerSys filed an 8-K on February 4, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, and Item 8.01 for Other Events. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or material impacts are disclosed.

UGI CORP /PA/8-Kneutralmateriality 3/10

04-02-2026

UGI Corp (/PA/) filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010315), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote outcomes, proposals, share counts, or quantitative results are disclosed in the provided filing information. This is a single-item informational filing with no financial metrics or period-over-period comparisons mentioned.

Moelis & Co8-Kneutralmateriality 8/10

04-02-2026

Moelis & Co (sector not specified) filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037612, Size: 1 MB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are mentioned.

FIREFLY NEUROSCIENCE, INC.8-Kneutralmateriality 7/10

04-02-2026

Firefly Neuroscience, Inc. filed an 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01 and departure/election of directors or certain officers, including compensatory arrangements of certain officers under Item 5.02. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, or quantitative impacts are disclosed.

Unknown8-Kneutralmateriality 5/10

04-02-2026

The company filed an 8-K on February 04, 2026 (AccNo: 0001193125-26-037610), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue figures, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing for financial results with no quantitative data available for analysis.

Revolve Group, Inc.8-Kneutralmateriality 8/10

04-02-2026

Revolve Group, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant). Item 9.01 discloses Financial Statements and Exhibits. No transaction details, dollar values, financial metrics, or impacts are provided.

BANK OF THE JAMES FINANCIAL GROUP INC8-Kneutralmateriality 4/10

04-02-2026

BANK OF THE JAMES FINANCIAL GROUP INC filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of financial results without detailed directional data.

PTC INC.8-Kneutralmateriality 8/10

04-02-2026

PTC Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037588), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are provided in the filing summary. This is a standard voluntary earnings-related disclosure with no disclosed positive or negative performance indicators.

Equitable Holdings, Inc.8-Kneutralmateriality 7/10

04-02-2026

Equitable Holdings, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, or other metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or guidance changes are provided in the available information.

UNIVERSAL INSURANCE HOLDINGS, INC.8-Kneutralmateriality 4/10

04-02-2026

Universal Insurance Holdings, Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. This appears to be a multi-item, primarily voluntary disclosure to comply with Regulation FD requirements.

TransMedics Group, Inc.8-Kneutralmateriality 3/10

04-02-2026

TransMedics Group, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. Sector information is not specified.

e.l.f. Beauty, Inc.8-Kneutralmateriality 7/10

04-02-2026

e.l.f. Beauty, Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information.

CROWN HOLDINGS, INC.8-Kneutralmateriality 7/10

04-02-2026

Crown Holdings, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed metrics available.

Kinsale Capital Group, Inc.8-Kneutralmateriality 5/10

04-02-2026

Kinsale Capital Group, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on affected positions, individuals, reasons, or impacts are disclosed.

CuriosityStream Inc.8-Kneutralmateriality 3/10

04-02-2026

CuriosityStream Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events or contents of the exhibits are disclosed in the provided filing summary. This is an informational filing with no quantitative financial metrics, positive or negative changes, or material impacts explicitly stated.

BASSETT FURNITURE INDUSTRIES INC8-Kneutralmateriality 8/10

04-02-2026

Bassett Furniture Industries Inc filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were detailed in the provided filing information. This is a standard earnings-related disclosure with no quantified metrics available.

Snap Inc8-Kneutralmateriality 7/10

04-02-2026

Snap Inc filed a Form 8-K on February 4, 2026 (AccNo: 0001564408-26-000011, Size: 5 MB), reporting Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the provided filing information. This appears to be a standard multi-item earnings-related disclosure.

BLACK HILLS CORP /SD/8-Kneutralmateriality 7/10

04-02-2026

Black Hills Corp (/SD/) filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037663), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a financial results disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided information. The filing size is 22 MB, suggesting attachments like earnings materials may be included.

Helmerich & Payne, Inc.8-Kneutralmateriality 7/10

04-02-2026

Helmerich & Payne, Inc. filed a Form 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a standard earnings-related filing, but no specific quantitative financial metrics, period-over-period comparisons, or directional performance data (positive, negative, or flat) are provided in the filing summary. No revenue, earnings, guidance, or balance sheet impacts are detailed.

Fluence Energy, Inc.8-Kneutralmateriality 8/10

04-02-2026

Fluence Energy, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

EZCORP INC8-Kneutralmateriality 6/10

04-02-2026

EZCORP INC filed a Form 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating disclosure of financial results likely via attached press release or statements. This is a multi-item filing focused on earnings-related information with no specific revenue, earnings, or other quantitative metrics detailed. No positive or negative performance indicators, guidance, or comparisons were provided in the filing metadata.

CSG SYSTEMS INTERNATIONAL INC8-Kneutralmateriality 8/10

04-02-2026

CSG Systems International Inc filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no quantified positive or negative metrics available.

ENSIGN GROUP, INC8-Kneutralmateriality 5/10

04-02-2026

Ensign Group, Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing information.

LANTRONIX INC8-Kneutralmateriality 6/10

04-02-2026

Lantronix Inc filed an 8-K on February 4, 2026 (AccNo: 0001683168-26-000750), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, quantitative data, period-over-period comparisons, or other details are provided in the filing summary.

  • Β·Sector: NOT_DISCLOSED
StoneX Group Inc.8-Kneutralmateriality 7/10

04-02-2026

StoneX Group Inc. filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance data available.

NETGEAR, INC.8-Kneutralmateriality 8/10

04-02-2026

NETGEAR, INC. filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037642), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other metrics are disclosed in the provided filing information.

Rexford Industrial Realty, Inc.8-Kneutralmateriality 7/10

04-02-2026

Rexford Industrial Realty, Inc. filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific financial metrics, period-over-period changes, guidance, or other quantitative data are provided in the filing summary. No positive or negative performance indicators are available.

DHI GROUP, INC.8-Kneutralmateriality 7/10

04-02-2026

DHI Group, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001393883-26-000030), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No positive, negative, or flat performance indicators are provided in the filing details.

GREENBRIER COMPANIES INC8-Kneutralmateriality 8/10

04-02-2026

Greenbrier Companies Inc filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, transaction size, parties involved, financial terms, or impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

Tenable Holdings, Inc.8-Kneutralmateriality 8/10

04-02-2026

Tenable Holdings, Inc. filed an 8-K on February 04, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Detailed financial metrics, transaction values, or operational impacts are NOT_DISCLOSED.

PVH CORP. /DE/8-Kneutralmateriality 2/10

04-02-2026

PVH Corp. /DE/ filed an 8-K on February 4, 2026 (AccNo: 0000078239-26-000005, size 190 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed. This appears to be a multi-item filing likely including attached documents such as a press release.

COPT DEFENSE PROPERTIES8-Kneutralmateriality 5/10

04-02-2026

COPT DEFENSE PROPERTIES filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason, timing, or any quantitative data are disclosed.

MONARCH CASINO & RESORT INC8-Kneutralmateriality 7/10

04-02-2026

Monarch Casino & Resort Inc filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a multi-item filing announcing financial results with attached exhibits.

Mueller Water Products, Inc.8-Kneutralmateriality 8/10

04-02-2026

Mueller Water Products, Inc. filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, guidance, or period-over-period metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure without quantified performance data.

NLIGHT, INC.8-Kneutralmateriality 3/10

04-02-2026

NLIGHT, INC. filed a Form 8-K on 2026-02-04 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information. This appears to be an informational filing with attached exhibits, but core event content is not available.

MODINE MANUFACTURING CO8-Kneutralmateriality 7/10

04-02-2026

Modine Manufacturing Co filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010338, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary.

Launchpad Cadenza Acquisition Corp I8-Kneutralmateriality 7/10

04-02-2026

Launchpad Cadenza Acquisition Corp I filed an 8-K on 2026-02-04 disclosing a merger/acquisition event under Item 8.01 (Other Events) and providing financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, financial impacts, positive or negative performance indicators, or period-over-period comparisons are disclosed in the provided filing summary. Critical details such as parties involved, valuation, structure, and strategic rationale remain NOT_DISCLOSED.

GLOBE LIFE INC.8-Kneutralmateriality 7/10

04-02-2026

Globe Life Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics were mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

  • Β·AccNo: 0000320335-26-000029
  • Β·Filing size: 647 KB
  • Β·Sector: not specified
Pacific Oak Strategic Opportunity REIT, Inc.8-Kbearishmateriality 8/10

04-02-2026

Pacific Oak Strategic Opportunity REIT, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 2.04 a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details on the nature of the event, dollar value, financial impact, or related metrics were disclosed. This mandatory disclosure signals potential financial stress but lacks quantification for precise assessment.

STEWART INFORMATION SERVICES CORP8-Kneutralmateriality 7/10

04-02-2026

Stewart Information Services Corp filed an 8-K on February 04, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure with AccNo: 0001104659-26-010325 and file size 566 KB.

NOODLES & Co8-Kneutralmateriality 3/10

04-02-2026

Noodles & Co filed a Form 8-K on February 4, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on vote outcomes, the nature of other events, or contents of exhibits are disclosed. This multi-item filing provides informational disclosure without quantified financial metrics or directional impacts.

WEX Inc.8-Kneutralmateriality 6/10

04-02-2026

WEX Inc. filed an 8-K on February 4, 2026 (AccNo: 0001309108-26-000005), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified performance details.

GLADSTONE CAPITAL CORP8-Kneutralmateriality 5/10

04-02-2026

Gladstone Capital Corp filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037714), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, or other quantitative metrics are provided in the filing summary. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are mentioned.

GenFlat Holdings, Inc.8-Kneutralmateriality 7/10

04-02-2026

GenFlat Holdings, Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the available information. This is a multi-item filing with no quantitative data or performance metrics disclosed.

GigCapital7 Corp.8-Kneutralmateriality 7/10

04-02-2026

GigCapital7 Corp. filed an 8-K on February 04, 2026, reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, under Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure of potentially material events, but no specific transaction sizes, dollar values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in informational disclosure without directional bias.

Krispy Kreme, Inc.8-Kneutralmateriality 3/10

04-02-2026

Krispy Kreme, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or implications are disclosed. This is a routine disclosure with no quantitative metrics, positive or negative changes reported.

USCB FINANCIAL HOLDINGS, INC.8-Kneutralmateriality 5/10

04-02-2026

USCB Financial Holdings, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for change, or quantitative data are disclosed.

Victory Capital Holdings, Inc.8-Kneutralmateriality 7/10

04-02-2026

Victory Capital Holdings, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037708), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.

KINGSTONE COMPANIES, INC.8-Kneutralmateriality 8/10

04-02-2026

Kingstone Companies, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001021771-26-000016), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing for financial results with no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics provided in the available information. No positive or negative financial changes can be assessed due to lack of quantitative details.

COLUMBUS MCKINNON CORP8-Kmixedmateriality 8/10

04-02-2026

Columbus McKinnon Corp filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01), termination of a prior material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in directors or officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). The filing signals a merger/acquisition event but includes both positive developments like acquisition completion and potentially negative ones like agreement termination and new financial obligations. Specific details on parties, deal structure, values, and impacts are NOT_DISCLOSED.

ALLIANCE RESOURCE PARTNERS LP8-Kneutralmateriality 8/10

04-02-2026

Alliance Resource Partners LP filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits, likely including the agreement document. No specific details on the agreement terms, transaction value, parties, financial impacts, or metrics are disclosed.

Aramark8-Kneutralmateriality 3/10

04-02-2026

Aramark filed an 8-K on February 4, 2026, specifically reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a mandatory disclosure of shareholder vote results from a recent meeting. No specific proposals, vote outcomes, numerical results, or other details are disclosed.

American Healthcare REIT, Inc.8-Kneutralmateriality 6/10

04-02-2026

American Healthcare REIT, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

  • Β·Filing accession number: 0001193125-26-037696
  • Β·Filing size: 214 KB
O REILLY AUTOMOTIVE INC8-Kneutralmateriality 9/10

04-02-2026

O'Reilly Automotive Inc. filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02 and attaching financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure for the company in the US equity market. Specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED.

STERIS plc8-Kneutralmateriality 8/10

04-02-2026

STERIS plc filed a Form 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing description. This appears to be a standard earnings-related disclosure with exhibits likely containing detailed financial statements.

Murphy USA Inc.8-Kneutralmateriality 8/10

04-02-2026

Murphy USA Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001573516-26-000026), under Item 2.02 disclosing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are provided in the filing summary. This is a standard earnings-related disclosure with no detailed performance data available.

ASBURY AUTOMOTIVE GROUP INC8-Kneutralmateriality 6/10

04-02-2026

Asbury Automotive Group Inc filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals affected, reasons for changes, financial impacts, or quantitative metrics are disclosed.

STIFEL FINANCIAL CORP8-Kneutralmateriality 7/10

04-02-2026

Stifel Financial Corp filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided.

IF Bancorp, Inc.8-Kneutralmateriality 3/10

04-02-2026

IF Bancorp, Inc. filed a Form 8-K on February 04, 2026, reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on voting outcomes, events, financial statements, or exhibits are disclosed. No quantitative metrics, transactions, or performance data provided.

SILGAN HOLDINGS INC8-Kneutralmateriality 7/10

04-02-2026

Silgan Holdings Inc filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005470), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

bioAffinity Technologies, Inc.8-Kneutralmateriality 5/10

04-02-2026

bioAffinity Technologies, Inc. filed a Form 8-K on 2026-02-04 under Item 8.01 Other Events. No details regarding the specific nature of the event, financial metrics, transactions, or operational impacts are disclosed in the provided filing information. Sector is not specified, and no quantitative data or comparisons are mentioned.

WRAP TECHNOLOGIES, INC.8-Kneutralmateriality 7/10

04-02-2026

WRAP Technologies, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, dollar values, share counts, or financial impacts for these items are disclosed. This is a multi-item filing with no period-over-period comparisons or guidance provided.

Post Holdings, Inc.8-Kneutralmateriality 6/10

04-02-2026

Post Holdings, Inc. filed a Form 8-K on February 4, 2026, disclosing events under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing reports governance-related changes and outcomes from a shareholder vote, but no specific details, vote results, amendment descriptions, or financial metrics are provided in the available information. No positive or negative performance metrics are mentioned.

STAR GROUP, L.P.8-Kneutralmateriality 7/10

04-02-2026

STAR GROUP, L.P. filed an 8-K on 2026-02-04 reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons are disclosed in the provided filing description. This is a multi-item filing focused on financial results without quantified data available here.

ADIAL PHARMACEUTICALS, INC.8-Kneutralmateriality 7/10

04-02-2026

Adial Pharmaceuticals, Inc. filed an 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons disclosed. No quantitative impacts or directional biases are evident from the available information.

Coeptis Therapeutics Holdings, Inc.8-Kneutralmateriality 2/10

04-02-2026

Coeptis Therapeutics Holdings, Inc. filed an 8-K on February 04, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific proposals, vote outcomes, or numerical results are disclosed in the provided filing information. No financial metrics, changes, or other quantitative data are mentioned.

MIDDLEBY Corp8-Kneutralmateriality 4/10

04-02-2026

Middleby Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative impacts are disclosed.

XTI Aerospace, Inc.8-Kneutralmateriality 8/10

04-02-2026

XTI Aerospace, Inc. filed an 8-K on 2026-02-04 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside changes in directors or certain officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties involved, or performance comparisonsβ€”positive, negative, or flatβ€”are provided in the filing summary. This informational filing signals a completed material transaction but lacks details to assess impact.

  • Β·AccNo: 0001213900-26-012273
  • Β·File size: 867 KB
WOLFSPEED, INC.8-Kneutralmateriality 7/10

04-02-2026

Wolfspeed, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

iQSTEL Inc8-Kneutralmateriality 4/10

04-02-2026

iQSTEL Inc filed a Form 8-K on February 4, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on vote matters, outcomes, the nature of other events, or exhibit contents are disclosed. No quantitative metrics, financial impacts, or directional biases are provided in the filing summary.

Flowco Holdings Inc.8-Kneutralmateriality 3/10

04-02-2026

Flowco Holdings Inc. filed a Form 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the filing summary. This multi-item filing provides limited informational disclosure without quantified impacts.

Maze Therapeutics, Inc.8-Kmixedmateriality 8/10

04-02-2026

Maze Therapeutics, Inc. filed a Form 8-K on February 04, 2026, reporting entry into a new material definitive agreement under Item 1.01, termination of a prior material definitive agreement under Item 1.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. This multi-item filing signals significant contractual changes and new obligations, but no specific details, dollar values, or strategic context were disclosed. The combination suggests potential strategic shifts offset by new financial commitments.

Regional Management Corp.8-Kneutralmateriality 7/10

04-02-2026

Regional Management Corp. filed a Form 8-K on 2026-02-04 reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information. This is a multi-item filing typical for earnings announcements, but lacks detailed performance data for analysis.

STANDEX INTERNATIONAL CORP/DE/8-Kneutralmateriality 8/10

04-02-2026

Standex International Corp/DE/ filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a standard disclosure of financial results with attached exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information.

Unknown8-Kneutralmateriality 8/10

04-02-2026

The company filed an 8-K on February 4, 2026 (AccNo: 0000921825-26-000008), disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. This is a standard financial results announcement, likely including an earnings press release as an exhibit. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.

Grayscale CoinDesk Crypto 5 ETF8-Kneutralmateriality 1/10

04-02-2026

Grayscale CoinDesk Crypto 5 ETF filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037738, Size: 162 KB) under Item 8.01 reporting Other Events. No specific details on the nature of the event, transaction values, financial metrics, positive or negative impacts, or comparisons are disclosed. Sector is not specified.

Cerence Inc.8-Kneutralmateriality 7/10

04-02-2026

Cerence Inc. filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005491), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings announcements, with file size of 6 MB.

U-Haul Holding Co /NV/8-Kneutralmateriality 5/10

04-02-2026

U-Haul Holding Co /NV/ filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics were mentioned in the provided filing information. No positive, negative, or flat performance indicators are available.

Unknown8-Kneutralmateriality 8/10

04-02-2026

The company filed a Form 8-K on February 04, 2026 (AccNo: 0001140361-26-003709, Size: 4 MB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results event, likely an earnings release. No specific revenue, earnings, guidance, period-over-period metrics, or other quantitative financial details are provided in the filing excerpt.

MARKEL GROUP INC.8-Kneutralmateriality 7/10

04-02-2026

Markel Group Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing announcing financial results with no specific quantitative metrics, comparisons, positive or negative changes detailed in the provided information. No guidance, scheduled events, or other material details were explicitly stated.

PHIBRO ANIMAL HEALTH CORP8-Kneutralmateriality 5/10

04-02-2026

Phibro Animal Health Corp filed an 8-K on February 04, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results without detailed performance data.

Uniti Group Inc.8-Kneutralmateriality 8/10

04-02-2026

Uniti Group Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

Rubrik, Inc.8-Kneutralmateriality 5/10

04-02-2026

Rubrik, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. No specific details on the officer position affected, appointment/resignation status, reasons, timing, financial metrics, or quantitative data are disclosed. Sector is not specified.

Kimball Electronics, Inc.8-Kneutralmateriality 7/10

04-02-2026

Kimball Electronics, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001606757-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing description. This appears to be a standard voluntary earnings release without detailed performance data available.

Core Laboratories Inc. /DE/8-Kneutralmateriality 8/10

04-02-2026

Core Laboratories Inc. filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item voluntary disclosure typical for earnings releases. No specific revenue, earnings, or other financial metrics are disclosed.

COMPASS MINERALS INTERNATIONAL INC8-Kneutralmateriality 7/10

04-02-2026

Compass Minerals International Inc filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.

ACM Research, Inc.8-Kneutralmateriality 3/10

04-02-2026

ACM Research, Inc. filed an 8-K on February 04, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information. This appears to be a multi-item voluntary disclosure with no quantified impacts mentioned.

ASGN Inc8-Kneutralmateriality 7/10

04-02-2026

ASGN Inc filed an 8-K on February 4, 2026 (AccNo: 0000890564-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing furnishing financial results. Specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are NOT_DISCLOSED.

MATRIX SERVICE CO8-Kneutralmateriality 4/10

04-02-2026

Matrix Service Co filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are mentioned in the filing description. This is a standard informational disclosure for financial results with no directional data provided.

FIRST UNITED CORP/MD/8-Kneutralmateriality 7/10

04-02-2026

FIRST UNITED CORP/MD/ filed a Form 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are disclosed in the provided filing information. This is a multi-item, likely voluntary disclosure related to earnings release.

METLIFE INC8-Kneutralmateriality 8/10

04-02-2026

MetLife Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but specific revenue, earnings, or other metrics are NOT_DISCLOSED. No positive or negative performance details provided.

National Bank Holdings Corp8-Kneutralmateriality 5/10

04-02-2026

National Bank Holdings Corp filed an 8-K on February 04, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the Regulation FD disclosure or the attached exhibits are disclosed in the provided filing information.

Orange County Bancorp, Inc. /DE/8-Kneutralmateriality 5/10

04-02-2026

Orange County Bancorp, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing details. This is purely informational without directional financial data.

Unknown8-Kneutralmateriality 3/10

04-02-2026

The company filed an 8-K on February 4, 2026, disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on transaction size, share counts, parties involved, financial impact, or the nature of other events are provided. This multi-item filing appears informational with exhibits likely containing further details.

FMC CORP8-Kneutralmateriality 9/10

04-02-2026

FMC Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related filing with no directional performance indicators available.

Evercore Inc.8-Kneutralmateriality 3/10

04-02-2026

Evercore Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.

SITIME Corp8-Kneutralmateriality 9/10

04-02-2026

SiTime Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037802, Size: 6 MB), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for the material agreement, with Regulation FD potentially voluntary if triggered. No specific details on the agreement terms, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

Ralliant Corp8-Kneutralmateriality 7/10

04-02-2026

Ralliant Corp filed a Form 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other quantitative metrics. No positive or negative performance indicators, guidance, or comparisons are detailed in the provided filing information.

Unknown8-Kneutralmateriality 6/10

04-02-2026

The filer submitted a Form 8-K on 2026-02-04 under Items 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year) and 9.01 (Financial Statements and Exhibits), with the exhibit being a Credit Agreement. No specific details on the nature of the amendments, fiscal year changes, or terms of the Credit Agreement such as size, parties, maturity, interest rates, or covenants are disclosed. Critical transaction and financial metrics are absent from the provided filing information.

  • Β·Filing Accession Number: 0001316944-26-000019
  • Β·Filing Size: 265 KB
  • Β·Event Date: 2026-02-04
Laser Photonics Corp8-Kneutralmateriality 7/10

04-02-2026

Laser Photonics Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, appointment or resignation status, reasons for change, and any governance implications are NOT_DISCLOSED.

GEOSPACE TECHNOLOGIES CORP8-Kneutralmateriality 6/10

04-02-2026

GEOSPACE TECHNOLOGIES CORP filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard voluntary earnings release filing.

CADIZ INC8-Kneutralmateriality 3/10

04-02-2026

Cadiz Inc filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any financial metrics are disclosed in the provided filing summary. This appears to be a routine governance disclosure with no additional quantitative or qualitative context provided.

CION Investment Corp8-Kneutralmateriality 8/10

04-02-2026

CION Investment Corp filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's parties, terms, value, or financial implications are provided. This is a multi-item mandatory filing with no quantitative metrics or performance comparisons disclosed.

Confluent, Inc.8-Kneutralmateriality 1/10

04-02-2026

Confluent, Inc. filed a Form 8-K on February 4, 2026, under Item 8.01 disclosing Other Events. No details on the core event, financial impacts, quantitative metrics, or strategic implications were provided in the filing information. No positive or negative metrics mentioned.

GAXOS.AI INC.8-Kneutralmateriality 2/10

04-02-2026

GAXOS.AI INC. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events or contents of the exhibits are disclosed in the provided filing summary. No financial metrics, transactions, or impacts are mentioned.

Space Asset Acquisition Corp.8-Kneutralmateriality 5/10

04-02-2026

Space Asset Acquisition Corp. filed an 8-K on February 4, 2026 (AccNo: 0001213900-26-012366), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, or strategic rationale were detailed in the filing summary provided. Sector details were not specified.

Luminar Technologies, Inc./DE8-Kneutralmateriality 8/10

04-02-2026

Luminar Technologies, Inc./DE filed an 8-K on February 4, 2026, disclosing the termination of a material definitive agreement under Item 1.02 and the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 references financial statements and exhibits, but no specific financial metrics, parties, or terms were detailed. This filing provides informational updates on transactional events without quantified impacts.

UPEXI, INC.8-Kneutralmateriality 8/10

04-02-2026

UPEXI, INC. filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement terms, transaction value, parties involved, financial impacts, or other metrics are disclosed in the provided filing summary. This represents a mandatory disclosure of a material event without quantitative data or directional implications.

GE Vernova Inc.8-Kneutralmateriality 2/10

04-02-2026

GE Vernova Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are mentioned, resulting in no identifiable positive or negative impacts.

Envirotech Vehicles, Inc.8-Kneutralmateriality 5/10

04-02-2026

Envirotech Vehicles, Inc. filed an 8-K on February 4, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 5.07 submission of matters to a vote of security holders and Item 9.01 financial statements and exhibits. Specific details including names, positions affected, reasons for changes, voting outcomes, or exhibit contents are NOT_DISCLOSED.

KRAKacquisition Corp8-Kneutralmateriality 3/10

04-02-2026

KRAKacquisition Corp filed an 8-K on 2026-02-04 (AccNo: 0001140361-26-003733, Size: 386 KB) disclosing Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits in connection with a labeled Merger/Acquisition event. No deal structure, parties involved, valuation, financial terms, strategic rationale, synergies, regulatory pathway, or shareholder impacts are explicitly stated or quantified in the provided filing details. Sector is not specified, with no positive or negative metrics, comparisons, or scheduled events disclosed.

  • Β·Critical missing information: Deal structure, parties (acquirer/target), valuation (equity/enterprise value), consideration type (cash/stock), strategic rationale, synergies, EPS impact, regulatory approvals, shareholder vote details, timeline, and sector context - all required for full M&A analysis
REGIONS FINANCIAL CORP8-Kneutralmateriality 4/10

04-02-2026

REGIONS FINANCIAL CORP filed an 8-K on February 04, 2026, reporting Item 5.03 regarding amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits, likely the amended documents. No quantitative financial metrics, transaction values, positive or negative changes, or specific details on the amendments were mentioned.

CUMBERLAND PHARMACEUTICALS INC8-Kneutralmateriality 3/10

04-02-2026

Cumberland Pharmaceuticals Inc filed a Form 8-K on February 4, 2026 (AccNo: 0001087294-26-000011, Size: 180 KB), reporting solely under Item 8.01 Other Events. The core nature of the other event is NOT_DISCLOSED, with no financial metrics, quantitative data, period-over-period comparisons, or operational details provided. No positive, negative, or flat performance indicators are mentioned.

ORACLE CORP8-Kneutralmateriality 8/10

04-02-2026

Oracle Corp filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.

Southland Holdings, Inc.8-Kneutralmateriality 5/10

04-02-2026

Southland Holdings, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001829126-26-000959, Size: 261 KB), reporting under Item 8.01 Other Events. No specific details regarding the core event, transaction value, financial impacts, or metrics are disclosed in the provided filing information. No positive or negative performance metrics, guidance changes, or scheduled events are mentioned.

Vivakor, Inc.8-Kneutralmateriality 8/10

04-02-2026

Vivakor, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are mentioned.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 303 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US SEC Filings Daily Market Digest β€” February 03, 2026 | Gunpowder Blog